瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
瑞普生物(300119) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入224,896.21158,716.4899,409.6344,278.05208,425.04
营业收入224,896.21158,716.4899,409.6344,278.05208,425.04
二、营业总成本187,433.26131,439.7582,388.9136,181.26173,193.14
营业成本113,151.1677,853.7947,738.1321,707.24107,461.31
营业税金及附加2,220.401,514.421,023.98368.582,040.01
销售费用37,095.7926,662.1217,638.607,018.8634,407.42
管理费用15,777.7311,556.887,360.383,367.2014,281.86
财务费用1,893.981,434.16929.23513.361,734.69
研发费用17,294.1912,418.387,698.593,206.0213,267.85
资产减值损失----------
公允价值变动收益6,125.992,977.672,196.171,476.435,138.32
投资收益1,515.062,360.212,139.31-30.08405.09
其中:对联营企业和合营企业的投资收益2,135.492,343.252,131.15-35.8882.84
汇兑收益----------
三、营业利润56,523.0232,671.8421,589.039,853.4341,663.84
加:营业外收入295.8748.9411.5510.72342.37
减:营业外支出150.88112.2389.9445.81625.07
其中:非流动资产处置损失----------
四、利润总额56,668.0132,608.5521,510.639,818.3341,381.14
减:所得税费用5,566.333,118.462,163.241,068.054,004.15
五、净利润51,101.6729,490.1019,347.398,750.2837,376.99
归属于母公司所有者的净利润45,294.2127,369.8017,827.118,082.3534,669.87
少数股东损益5,807.472,120.301,520.28667.942,707.12
六、每股收益
基本每股收益(元/股)0.97720.59000.38430.17420.7488
稀释每股收益(元/股)0.97720.59000.38430.17420.7488
七、其他综合收益----------
八、综合收益总额51,101.6729,490.1019,347.398,750.2837,376.99
归属于母公司所有者的综合收益总额45,294.2127,369.8017,827.118,082.3534,669.87
归属于少数股东的综合收益总额5,807.472,120.301,520.28667.942,707.12
下载全部历史数据到excel中 返回页顶